This is approximately 4,167% of the daily recommended intake, which is intentionally high to compensate for reduced absorption during GLP-1 therapy
This means a vial reconstituted for the 2mg phase (which provides 5 weekly doses from a 10mg vial) should be used within about 5 weeks, which aligns perfectly with the 4-week dose escalation schedule plus a small buffer
[DOI] [PubMed] [Google Scholar] 136.Toda N., Nakanishitoda M
Previously, BPC 157 also counteracts colitis (in various models of colitis[30-35]) and its complications, such as fistulas[36-38], failed healing of anastomoses[30,34,38-40] and other gastrointestinal lesions that were otherwise poorly healed[2-8], given parenterally or per-orally
Archived from the original (PDF) on July 9, 2009